FDA shall submit
the final versions of the questionnaire and related material after
pre-testing for OMB approval using the change worksheet (83-C). The
study design is appropriate for the purpose of the study identified
in the supporting statement. However, in describing the data
collected and results of the analysis, FDA will clearly acknowledge
that the data does not provide nationally representative estimates
of consumer attitudes, knowledge, behaviors, etc.
Inventory as of this Action
Requested
Previously Approved
09/30/2004
09/30/2004
1
0
0
640
0
0
0
0
0
An experimental study of the
effectiveness of various possible interpretational aids to help
consumers understand and apply nutrient content claims about trans
fat that may appear on food labels.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.